Abstract:Background:The TAM receptor tyrosine kinases (Tyro3/Axl/Mer TK) are a subfamily of receptor tyrosine kinases, the role of which in autoimmune diseases such as systemic lupus erythematosus has been well explored, while their functions in rheumatoid arthritis (RA) remain largely unknown [1].Objectives:The study aimed to investigate the expression and clinical significance of Tyro3, Axl and MerTK on monocyte subsets in rheumatoid arthritis (RA).Methods:The expression of Tyro3, Axl and MerTK on CD14+ monocytes, nonclassical monocytes (NCM, CD14+CD16++), intermediate monocytes (IM, CD14++CD16+), and classical monocytes (CM, CD14++CD16-) were evaluated in peripheral blood of RA by flow cytometry and qPCR. And the correlation between the expression of Tyro3TK and MerTK on NCM, IM, and CM with RA patient clinical feature were further analyzed.Results:The results revealed that the expression of Tyro3TK on CD14+ monocytes was significantly upregulated in RA patients (F = 9.18, P < 0.0001), while there was no significant difference of the expression MerTK on HC, OA, and RA, and the expression of AxlTK was minimal (Fig 1). The expression of Tyro3TK on CM was significantly upregulated in RA patients as compared with HC and osteoarthritis (OA) patients (P < 0.05, Fig 2-3), and positively correlated with the disease manifestations, such as swollen joint count (SJC), tender joint count (TJC) and the disease activity score (Fig 4).Figure 1.The expression of Tyro3, Axl and MerTK on CD14+ monocytes is increased in RA. (a) Gating strategy for flow cytometry of Tyro3, Axl and MerTK on CD14+ monocytes. (b) The expression of Tyro3, Axl and MerTK on CD14+ monocytes were compared between HC (n = 40), OA (n = 27), and RA patients (n = 40). *P < 0.05, **P < 0.01, ns, not significant.Figure 2.The expression of Tyro3TK on IM and CM were increased in RA. (a) Gating strategy for flow cytometry of TAMTK on monocyte subsets. The expression of (b) Tyro3TK and (c) MerTK on NCM, IM, and CM were compared between HC (n = 40), OA (n = 27), and RA patients (n = 40). *P < 0.05, **P < 0.01, ***P < 0.001, ns, not significant.Figure 3.The mRNA expression of Tyro3TK on CM is increased in RA. (a) The mRNA expression of Tyro3TK on NCM, IM, and CM in HC (n = 3) and RA (n = 3) patients. (b) The mRNA expression of MerTK on NCM, IM, and CM in HC (n = 3) and RA (n = 3) patients. **P < 0.01.Conclusion:These findings indicate that Tyro3TK on CM was elevated in RA patients and correlated positively with disease activity, which may serves as an important participant in RA pathogenesis.References:[1]Rothlin CV, Lemke G, TAM receptor signaling and autoimmune disease. Curr Opin Immunol, 2010. 22(6): p. 740-6.Footnotes:The study was supported by grants from the National Natural Science Foundation of China (81671609 and 81871290 to Dr. Y. Su, 82001718 to Dr. L. Xu), the Beijing Science and Technology Planning Project (Z191100006619111 to Dr. Y. Su), the Beijing Municipal Natural Science Foundation (7194329 to Dr. L. Xu).Figure 4.Correlation analysis of Tyro3TK on IM and CM with RA patient clinical manifestations. The associations of Tyro3TK on IM (r = 0.492, *P = 0.001) (a) and CM (r = 0.577, *P = 0.0001) (b) with RA patient swollen joint counts (SJC) were analyzed, respectively. The expression of Tyro3TK on IM and CM were also compared between different RA patient groups: (c) RA with high disease activity (DAS28-ESR > 3.2) and non-high disease activity (DAS28-ESR ≤ 3.2), (d) RA with and without swollen joints, (e) tender joints. *P < 0.05, **P < 0.01.Disclosure of Interests:None declared

The Association of Tyro3/Axl/Mer Signaling with Inflammatory Response, Disease Activity in Patients with Primary Sjögren's Syndrome

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjogren's syndrome

Association de la signalisation Tyro3/Axl/Mer avec la réaction inflammatoire et l’activité de la maladie dans le syndrome de Gougerot-Sjögren primitif

Soluble TAM Receptor Tyrosine Kinases in Rheumatoid Arthritis: Correlation with Disease Activity and Bone Destruction

Mir‐146a and Mir‐155 Expression in PBMCs from Patients with Sjögren's Syndrome

Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis

Increased Expression of T Cell Immunoglobulin and Mucin-3 in Peripheral Blood Mononuclear Cells from Patients with Primary Sj¨ogren’s Syndrome and Its Clinical Significance

Analysis of Gene Expression and TCR/B Cell Receptor Profiling of Immune Cells in Primary Sjogren?s Syndrome by Single-Cell Sequencing

Identification of inflammatory markers as indicators for disease progression in primary Sjögren syndrome

Relationships Between Increased Circulating YKL-40, IL-6 and TNF-α Levels and Phenotypes and Disease Activity of Primary Sjögren's Syndrome.

Analysis of Gene Expression and TCR/B Cell Receptor Profiling of Immune Cells in Primary Sjögren's Syndrome by Single-Cell Sequencing.

Identification and Verification of Inflammatory Biomarkers for Primary Sjögren’s Syndrome

Attenuation of the BTLA/HVEM Regulatory Network in the Circulation in Primary Sjögren’s Syndrome

Mitochondria-related genes and metabolic profiles of innate and adaptive immune cells in primary Sjögren's syndrome

Mitochondria-related Genes and Metabolic Profiles of Innate and Adaptive Immune Cells in Primary Sjögren’s Syndrome

Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome

Increased CD200 Levels in Peripheral Blood Mononuclear Cells of Patients with Primary Sjögren's Syndrome.

AB0046 THE EXPRESSION AND CLINICAL SIGNIFICANCE OF TAM RECEPTOR TYROSINE KINASE ON MONOCYTE SUBSETS IN RHEUMATOID ARTHRITIS

Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjögren's syndrome

MicroRNA Profiling in Chinese Patients with Primary Sjögren Syndrome Reveals Elevated Mirna-181A in Peripheral Blood Mononuclear Cells.